- Home
- MGTX vs RERE Comparison
MGTX vs RERE Comparison
Compare MGTX & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- RERE
- Stock Information
- Founded
- MGTX 2015
- RERE 2011
- Country
- MGTX United States
- RERE China
- Employees
- MGTX N/A
- RERE N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- RERE Other Specialty Stores
- Sector
- MGTX Health Care
- RERE Consumer Discretionary
- Exchange
- MGTX Nasdaq
- RERE Nasdaq
- Market Cap
- MGTX 520.8M
- RERE 444.1M
- IPO Year
- MGTX N/A
- RERE 2021
- Fundamental
- Price
- MGTX $8.47
- RERE $3.56
- Analyst Decision
- MGTX Strong Buy
- RERE
- Analyst Count
- MGTX 2
- RERE 0
- Target Price
- MGTX $24.00
- RERE N/A
- AVG Volume (30 Days)
- MGTX 541.8K
- RERE 2.5M
- Earning Date
- MGTX 08-11-2025
- RERE 08-19-2025
- Dividend Yield
- MGTX N/A
- RERE N/A
- EPS Growth
- MGTX N/A
- RERE N/A
- EPS
- MGTX N/A
- RERE 0.07
- Revenue
- MGTX $34,508,000.00
- RERE $2,388,301,386.00
- Revenue This Year
- MGTX $365.04
- RERE $27.37
- Revenue Next Year
- MGTX $73.18
- RERE $24.06
- P/E Ratio
- MGTX N/A
- RERE $50.79
- Revenue Growth
- MGTX 203.23
- RERE 26.09
- 52 Week Low
- MGTX $3.85
- RERE $2.00
- 52 Week High
- MGTX $8.75
- RERE $4.35
- Technical
- Relative Strength Index (RSI)
- MGTX 76.43
- RERE 59.53
- Support Level
- MGTX $6.31
- RERE $3.49
- Resistance Level
- MGTX $8.75
- RERE $4.35
- Average True Range (ATR)
- MGTX 0.45
- RERE 0.29
- MACD
- MGTX 0.19
- RERE 0.03
- Stochastic Oscillator
- MGTX 89.55
- RERE 47.52
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.